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Pain in the newborn brain: a neural signature
No one wants to see a baby in pain. Yet, for many 
decades neonatal health-care providers have debated 
whether neonates feel pain and at what age this 
neural capacity emerges.1 This is a crucial issue because 
neonates who require intensive care are exposed to 
hundreds of painful procedures as part of life-saving 
medical procedures. Fortunately, clinicians now recog-
nise that neonates sense pain and that appropriate 
strategies for analgesia and sedation are needed for their 
compassionate care. In the past 10 years, in preterm 
neonates—a major population in neonatal intensive 
care units—pain has emerged as a key predictor of 
delayed brain maturation, which has been associated 
with subsequent neurodevelopmental impairments.2 
Despite the recognition that pain management is a key 
aspect of care for neonates, quantifying pain in newborn 
babies remains challenging. Neonatal pain assessments 
comprise observable indicators such as physiological 
changes (eg, heart rate), or behavioural indicators (eg, 
crying), which are influenced by contextual factors 
(eg, gestational age).1 Pain man agement with analgesics 
or sedatives in neonates is associated with regional 
brain dysmaturation in brain structures associated 
with memory and motor coordin ation.3–5 Therefore, 
the identification of objective pain measures is crucial 
to effectively manage pain but also to promote brain 
health and prevent childhood disabilities.
Evidence from functional MRI (fMRI) has shown 
noxious-stimulus evoked activation in pain-processing 
brain regions in newborn babies.6 Furthermore, 
functional-connectivity strength in core pain-processing 
regions is predicted by invasive procedures during 
intensive care in neonates.7 However, defining a unique 
pain signature in newborn babies is challenging due to 
the absence of subjective reports of pain. Unique neural 
signatures specific for noxious stimuli (neurologic 
pain signature [NPS])8 and cognitive pain modulation 
(stimulus intensity independent pain signature-1 
[SIIPS1])9 have been identified in adults. Whether similar 
signatures (NPS, SIIPS1) emerge within the first weeks of 
life has remained unclear due to challenges examining 
pain in infants.
In The Lancet Digital Health, Eugene Duff and 
colleagues10 address the issue of identifying objective 
brain-based biomarkers for pain in the newborn brain. 
Initially, the authors examined the NPS and SIIPS1 in 
ten adults who were administered varying intensities 
of noxious stimuli during fMRI. The adults rated the 
intensity of the stimuli. The activation patterns in adults 
were evaluated in relation to predefined signatures 
for the NPS, SIIPS1, and four control signatures (the 
vicarious pain signature, the picture-induced negative 
emotion signature, the social rejection signature, and 
a global signal signature).
Subsequently, in two prospective cohorts of healthy 
newborn babies, a similar stimulation protocol to that 
used in the adults, but consisting of milder intensities 
of noxious stimuli, was administered to elicit pain-
related activation during fMRI. The resulting neonatal 
statistical parametric maps for the stimulus intensities 
were transformed into adult-template space to enable 
a direct quantitative analysis with the adult signatures. 
Infants had high concordance with the NPS observed 
in adults, reflecting core pain-processing brain regions. 
These findings suggest that newborn babies process 
nociceptive input in a similar way to adults. By contrast, 
divergent associations were observed between the 
neonatal pain-evoked activation signatures and the 
SIIPS1 signature in the adult brain. Findings were 
interpreted by the authors to indicate a similarity in 
nociceptive processing between newborns and adults, 
whereas developing pain modulatory systems diverge 
between newborns and adults.
This study provides evidence for brain-derived bio-
markers of pain-evoked activation in the neonatal 
brain. A unique signature for the experience of neonatal 
pain might offer opportunities to assess pharmaceutical 
therapies and non-pharmacological interventions that 
might be more clinically efficacious than the currently 
available options for neonatal pain. Furthermore, the 
findings might be used to corroborate in-hospital 
monitoring methods such as electroencephalography 
and functional near infrared spectroscopy to monitor 
discomfort when infants are unable to reliably express 
this non-verbally. Novel functional imaging methods 
might be used to complement observable indicators 
of pain to improve pain management and ultimately 
brain health in neonates. 
The study by Duff and colleagues is important for 
understanding pain in the neonatal brain. Considering 
See Articles page e458
Comment
the importance of pain as a predictor of brain health 
in preterm neonates, a key next step will be to 
understand the developmental emergence of the fMRI 
signature identified in this study. Similarly, since most 
critically-ill neonates, such as those born preterm, with 
congenital heart disease, or with hypoxic–ischaemic 
encephalopathy, are repeatedly exposed to painful 
stimuli of varying intensities as part of intensive 
care practices (eg, surgeries, chest intubations, heel 
lances), identifying how the pain signature evolves 
over time will inform more optimal pain management 
strategies. Application of this new imaging signature 
might enable understanding of how available pain 
management strategies mitigate the cerebral response 
to pain. Improving the experience of pain will improve 
the trajectory of brain development of neonates who 
require life-saving care. Until these issues are addressed, 
neonatal health-care providers are reminded by Duff and 
colleagues to do all they can to minimise the exposure of 
babies to pain.
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